Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study (Q58964242)

From Wikidata
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
scientific article published on 01 August 2004
Language Label Description Also known as
English
Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study
scientific article published on 01 August 2004

    Statements

    title
    Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    15277255
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15277255%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    31 December 2019
    author name string

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q58964242&oldid=2169519864"